Navigation Links
Phase II Medical Manufacturing Selects IQMS for ERP Solution
Date:2/5/2008

EnterpriseIQ Supports Device Manufacturer's Continued Growth and Compliance

PASO ROBLES, Calif., Feb. 5 /PRNewswire/ -- IQMS, a leader in the design and development of Enterprise Resource Planning (ERP) software, has been selected by Phase II Medical Manufacturing for its comprehensive ERP software, EnterpriseIQ. As Phase II continues to excel in the medical device manufacturing industry, so does the level of visibility needed to manage the company's growth. Phase II is committed to continual quality and compliance as an FDA-approved, and ISO 9001:2000 and ISO 13485:2003 certified manufacturer. EnterpriseIQ supports this effort by enabling the company to best manage time-to-market and traceability, and sustain continued growth and conformance.

"Rapid expansion was taxing our spread-sheet based system," says Adam Prime, president of Phase II. "To remain competitive, we needed a robust ERP system that could grow with us and cost-effectively manage our quality and compliance issues. EnterpriseIQ was the perfect fit. With modules like Quality Medical, RealTime Machine Monitoring, and Customer Relationship Management, we now have more control over our core business data, and because EnterpriseIQ is scalable we are well prepared for long-term growth and success."

The Quality Medical and Device History Record (DHR) modules are included in EnterpriseIQ to address the unique needs of medical manufacturers. These modules facilitate better internal communication and collaboration while ensuring quality standards compliance with capabilities such as: adherence to TS13485 and ISO 9001 standards, and CFR and FDA requirements; up-front risk assessment; electronic signature and document control; complete audit trail of manufacturing processes; comprehensive Corrective Action/Preventive Action (CAPA); and non-conforming product review and tracking. With EnterpriseIQ, medical device manufacturers can streamline operations and product development to gain a stronger competitive advantage.

"Medical device manufacturers operate in one of the world's most highly regulated industries," says Randy Flamm, president and founder of IQMS. "IQMS is committed to helping manufacturers like Phase II succeed in their ever-changing and complex industry. We've tailored EnterpriseIQ specifically to make their jobs easier. That's why so many Class 1, 2 and 3 device manufacturers rely on IQMS as their single-source ERP provider. We are thrilled Phase II has joined them, and we look forward to helping Phase II accelerate their success for many years to come."

About Phase II

Founded in 1995 to serve the single-use medical product and device industry, Phase II Medical Manufacturing now provides design, development, manufacturing, packaging, shipping, and sterilization services to its customers. FDA registration, Canadian licensing, and ISO 9001:2000 and ISO 13485:2003 certification are maintained to ensure that current U.S. and international standards are satisfied. Phase II works closely with clients on a regular basis to ensure all devices meet or exceed specifications, and its commitment and dedication to customers is unmatched in the industry.

About IQMS

Since 1989, IQMS has been a pioneer in the design and development of ERP software for repetitive, process and discrete manufacturing industries. Today, IQMS provides leading real-time manufacturing, accounting, machine monitoring, quality control, supply chain, CRM and eBusiness solutions to the automotive, medical, packaging, consumer goods and other manufacturing markets. The only complete, single-source enterprise software solution, EnterpriseIQ offers real-time front office, accounting, manufacturing and supply chain management in a single database. With offices across North America, Europe and Asia, IQMS serves manufacturers around the world. Visit IQMS online at http://www.iqms.com.

IQMS and EnterpriseIQ are trademarks of IQMS. All other brand and product names are the trademarks of their respective companies.


'/>"/>
SOURCE IQMS
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Ovation further advances development pipeline with new phase III epilepsy study
2. AKELA Pharma Inc. announces positive results for the extension part of its Phase IIb Fentanyl TAIFUN(R) trial
3. Mannatech Launches Phase One of New Sales and Training Tools
4. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
5. Manic phase of bipolar disorder benefits from breast cancer medication
6. ARIZONA METH PROJECT Unveils Arizonas Anti-Meth Youth Pledge and Kicks Off Phase Two of Public Awareness Campaign
7. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
8. Alexza to Initiate the First Phase 3 Trial for AZ-004 (Staccato(R) Loxapine) in Late Q1 2008
9. Iomai Patch-Based Vaccine Cut Rate of Travelers Diarrhea by 75 Percent in Phase 2 Field Study
10. MetLife Foundation Begins New Phase of Award-Winning Parenting Skills Campaign in Collaboration with the Partnership for a Drug-Free America(R)
11. Labopharm completes enrolment for Phase III clinical study for its once-daily trazodone antidepressant drug
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2016)... ... May 26, 2016 , ... According to the Webster’s dictionary, a hippie ... chemical-laden beauty products, one company is going against the norm with a line of ... rising star in the green space is proud to announce its latest retail partnership ...
(Date:5/26/2016)... (PRWEB) , ... May 26, 2016 , ... HealthPostures, ergonomics ... Angle chair , furniture that may support women during pregnancy. Potential benefits of using ... feet, improved rest and comfort and healthier levels of sitting and standing. , Need ...
(Date:5/25/2016)... ... ... The United States Food and Drug Administration (FDA) has now cleared Capillus® ... date, the company is the first and only manufacturer of low level laser therapy ... alopecia. , “This new level of clearance substantiates what many physicians have experienced ...
(Date:5/25/2016)... ... May 25, 2016 , ... ... a Managing Partner at HealthScape Advisors. “Brad brings significant experience advising healthcare provider ... delivery system accelerates with the implementation of MACRA, we believe that continuing to ...
(Date:5/25/2016)... , ... May 25, 2016 , ... Furthering its position ... athletics, The National Center for Drug Free Sport (Drug Free Sport®) is excited to ... conference, to be held July 12 – 13 in Kansas City, MO, will gather ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... -- According to a new market research ... by Therapeutic Area (Oncology, Cosmeceutical/Plastic Surgery), by Application (Drug ... Hospitals/ Clinics) - Forecast to 2021", published by MarketsandMarkets, ... the forecast period of 2016 to 2021. This market ... from USD 117.3 Million in 2016, at a CAGR ...
(Date:5/25/2016)... 25, 2016  Zymo Research Corp. announced today ... reference materials that help researchers obtain the most ... analyses. The rapid growth of the study of ... have standard methods to improve the reproducibility and ... exist at every step of the measurement process ...
(Date:5/25/2016)... As illustrated by the Spring ... the numbers and momentum of cannabis in the US ... billions, more research and development push the sector forward. ... Legal Marijuana Markets Report  from from ArcView Market Research ... the increase in sector is attributed to adult use ...
Breaking Medicine Technology: